XML 22 R7.htm IDEA: XBRL DOCUMENT v3.24.1
Consolidated Statements of Stockholders’ Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Cumulative-effect adjustment from adoption of ASU 2020-06
Restricted Stock Units
Restricted Stock
Common Stock
Common Stock
Restricted Stock Units
Common Stock
Restricted Stock
Additional Paid-In Capital
Additional Paid-In Capital
Cumulative-effect adjustment from adoption of ASU 2020-06
Additional Paid-In Capital
Restricted Stock Units
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Accumulated Deficit
Cumulative-effect adjustment from adoption of ASU 2020-06
Beginning balance (in shares) at Jan. 31, 2021         278,363                
Beginning balance at Jan. 31, 2021 $ 750,006       $ 28     $ 2,307,580     $ 7,410 $ (1,565,012)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Issuance of common stock upon exercise of stock options (in shares)         5,955                
Issuance of common stock upon exercise of stock options 48,543             48,543          
Stock-based compensation expense 289,185             289,185          
Vesting of restricted stock units (in shares)           12,955              
Vesting of restricted stock units     $ 0     $ 1       $ (1)      
Cancellation and forfeiture of restricted stock (in shares)             (62)            
Cancellation and forfeiture of restricted stock       $ 0                  
Tax withholding on vesting of equity awards (in shares)         (454)                
Tax withholding on vesting of equity awards (10,835)             (10,835)          
Common stock issued under employee stock purchase plan (in shares)         4,365                
Common stock issued under employee stock purchase plan 36,641             36,641          
Repurchase of common stock (in shares)         (8,489)                
Repurchases of common stock (200,170)             (200,170)          
Other comprehensive income (loss) (15,775)                   (15,775)    
Net income (loss) (143,259)                     (143,259)  
Ending balance (in shares) at Feb. 06, 2022         292,633                
Ending balance at Feb. 06, 2022 $ 754,336 $ (35,127)     $ 29     2,470,943 $ (133,265)   (8,365) (1,708,271) $ 98,138
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Accounting Standards Update [Extensible Enumeration] Accounting Standards Update 2020-06 [Member]                        
Issuance of common stock upon exercise of stock options (in shares)         2,988                
Issuance of common stock upon exercise of stock options $ 25,073             25,073          
Stock-based compensation expense 329,723             329,723          
Vesting of restricted stock units (in shares)           13,916              
Vesting of restricted stock units     0     $ 1       (1)      
Tax withholding on vesting of equity awards (in shares)         (643)                
Tax withholding on vesting of equity awards (19,601)             (19,601)          
Common stock issued under employee stock purchase plan (in shares)         3,014                
Common stock issued under employee stock purchase plan 39,965             39,965          
Repurchase of common stock (in shares)         (7,832)                
Repurchases of common stock (219,068)             (219,068)          
Other comprehensive income (loss) (7,139)                   (7,139)    
Net income (loss) 73,071                     73,071  
Ending balance (in shares) at Feb. 05, 2023         304,076                
Ending balance at Feb. 05, 2023 941,233       $ 30     2,493,769     (15,504) (1,537,062)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Issuance of common stock upon exercise of stock options (in shares)         4,770                
Issuance of common stock upon exercise of stock options 39,734             39,734          
Stock-based compensation expense 337,146             337,146          
Vesting of restricted stock units (in shares)           14,038              
Vesting of restricted stock units     $ 0     $ 2       $ (2)      
Tax withholding on vesting of equity awards (in shares)         (909)                
Tax withholding on vesting of equity awards (29,984)             (29,984)          
Common stock issued under employee stock purchase plan (in shares)         2,233                
Common stock issued under employee stock purchase plan 45,089             45,089          
Repurchase of common stock (in shares)         (4,686)                
Repurchases of common stock (135,801)             (135,801)          
Issuance of common stock upon conversion of convertible senior notes (in shares)         1                
Issuance of common stock upon conversion of convertible senior notes (356)             (356)          
Other comprehensive income (loss) 11,722                   11,722    
Net income (loss) 61,311                     61,311  
Ending balance (in shares) at Feb. 04, 2024         319,523                
Ending balance at Feb. 04, 2024 $ 1,270,094       $ 32     $ 2,749,595     $ (3,782) $ (1,475,751)